Prospective renal insufficiency cohort evaluation: PRICE
前瞻性肾功能不全队列评估:PRICE
基本信息
- 批准号:10207602
- 负责人:
- 金额:$ 68.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-28 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerometerAcuteAddressAdultAlbuminsAmbulatory Blood Pressure MonitoringAncillary StudyApple watchAreaBioinformaticsBiologicalBiological MarkersBiometryBreathingCardiovascular DiseasesCardiovascular systemCessation of lifeChronic Kidney FailureChronic Kidney InsufficiencyClinicalCohort StudiesCollaborationsCommunitiesComplexCreatinineDataData Coordinating CenterDevelopmentDevicesDisease ProgressionDocumentationElectrocardiogramEnrollmentEnsureEvaluationEventFeasibility StudiesFibroblast Growth FactorFundingGoalsGrantHealthHeart DiseasesHeart failureHomeHourImpairmentIndividualInstitutionKidneyKidney DiseasesKidney FailureLearningLettersManuscriptsMeasurementMeasuresMedical GeneticsMedical RecordsMethodologyMethodsMissionMonitorNational Institute of Diabetes and Digestive and Kidney DiseasesOlder PopulationOutcomePaperParentsParticipantPatient RecruitmentsPatient Self-ReportPennsylvaniaPhasePhenotypePhiladelphiaPhysical activityPilot ProjectsPopulationProceduresProductivityProgress ReportsProteinsProteinuriaProtocols documentationPublishingQuality ControlQuestionnairesRenal functionResearchResearch PersonnelResourcesRiskRisk FactorsRoleScheduleScienceSiteSpecimenStandardizationTechnologyUniversitiesUrineVariantWritingbaseclinical centercohortdata sharingdesignexperiencefitbitfollow-upheart rate variabilityhuman subjectinnovationkidney dysfunctionlongitudinal datasetmeetingsmembernew technologynovelparticipant retentionphenotypic dataprogramsprospectivequality assurancerecruitresponsetherapy design
项目摘要
PROJECT SUMMARY
The CRIC Study was initiated in 2001 and enrolled its first participants in mid 2003. In the intervening
years the CRIC Study has consistently met recruitment goals in Phase 1 and Phase 3, and
maintained a high level of participant follow up during the study. We have published over 150
manuscripts and are entering the potential for a fourth phase (2018-2023) of funding during which we
hope to follow up the newly recruited participants from Phase 3 (2013-2017; n=1520) and those from
Phase 1 (2003-2008; n=3939) who are still active in the study.
We propose 12 Specific Aims that are common to each clinical center in this competing U01 renewal
application and provide background and methodology to incorporate and number of new
measurements into the CRIC Study. In particular, we are adding innovative measures that record 48
hours of heart rate variability, physical activity by accelerometry and breathing rate via the Zephyr
BioPatch, and 14 days of continuous ECG monitoring via the ZIO XT Patch. In addition, we plan
obtain measures of in-home monitoring for subclinical episodes of AKI using current technologies that
allow a fingerstick creatinine measurement and urine protein, albumin and creatinine measures to be
obtained at home and uploaded to the CRIC clinical center. In this application we will focus on our
Center's productivity in the CRIC study and in particular will showcase the remarkable opportunity
available in the understanding of heart failure, the single most common CV endpoint in the CRIC
study, through biometric monitoring using these new technologies, along with our site's experience
with a pilot study in this area.
In this application we will review important aspects of CKD and contributions of our clinical center to
the CRIC effort. This application includes a progress report from our site (101) as well as proposals
for data sharing and the recruitment of investigators at our Institution as well as outside our Institution
to participate in evaluating and publishing findings from this landmark study in the Nephrologic
Community that will further the mission of the NIDDK to promote kidney health and to design
interventions that mitigate the burden of CKD in the US adult populations with CKD.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBBIE L COHEN其他文献
DEBBIE L COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBBIE L COHEN', 18)}}的其他基金
Lifestyle Modification and blood Pressure Study (LIMBS)
生活方式改变和血压研究 (LIMBS)
- 批准号:
8456216 - 财政年份:2009
- 资助金额:
$ 68.93万 - 项目类别:
Lifestyle Modification and blood Pressure Study (LIMBS)
生活方式改变和血压研究 (LIMBS)
- 批准号:
8281344 - 财政年份:2009
- 资助金额:
$ 68.93万 - 项目类别:
Lifestyle Modification and blood Pressure Study (LIMBS)
生活方式改变和血压研究 (LIMBS)
- 批准号:
8062290 - 财政年份:2009
- 资助金额:
$ 68.93万 - 项目类别:
Lifestyle Modification and blood Pressure Study (LIMBS)
生活方式改变和血压研究 (LIMBS)
- 批准号:
7662892 - 财政年份:2009
- 资助金额:
$ 68.93万 - 项目类别:
Lifestyle Modification and blood Pressure Study (LIMBS)
生活方式改变和血压研究 (LIMBS)
- 批准号:
7807019 - 财政年份:2009
- 资助金额:
$ 68.93万 - 项目类别:
CALCINEURIN INHIBITION AND DIABETES MELLITUS IN HEPATITIS C
丙型肝炎中钙调磷酸酶的抑制与糖尿病
- 批准号:
7199012 - 财政年份:2004
- 资助金额:
$ 68.93万 - 项目类别:
Calcineurin Inhibition & Diabetes Mellitus in Hepatitis
钙调磷酸酶抑制
- 批准号:
7039555 - 财政年份:2003
- 资助金额:
$ 68.93万 - 项目类别:
Prospective renal insufficiency cohort evaluation: PRICE
前瞻性肾功能不全队列评估:PRICE
- 批准号:
10466834 - 财政年份:2001
- 资助金额:
$ 68.93万 - 项目类别:
Prospective renal insufficiency cohort evaluation: PRICE
前瞻性肾功能不全队列评估:PRICE
- 批准号:
10731527 - 财政年份:2001
- 资助金额:
$ 68.93万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 68.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 68.93万 - 项目类别:
Operating Grants














{{item.name}}会员




